Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02483819
Other study ID # 4-2015-0362
Secondary ID
Status Completed
Phase N/A
First received June 18, 2015
Last updated January 24, 2017
Start date July 2, 2015
Est. completion date February 27, 2016

Study information

Verified date January 2017
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate the change of the hemodynamic profiles on bio reactance technique during TURP in elderly patients.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 27, 2016
Est. primary completion date February 27, 2016
Accepts healthy volunteers No
Gender Male
Age group 65 Years to 80 Years
Eligibility Inclusion Criteria:

1) Twenty (ASA status I ~ III) patients, ages 65 to 80 yr old, who were scheduled for transurethral resection of the prostate under spinal anesthesia

Exclusion Criteria:

1. if there were contraindications for spinal anesthesia including hypersensitivity to any local anaesthetics, bleeding diathesis, infections at the puncture sites, or pre-existing neurological disease.

2. history of coronary artery bypass surgery

3. history of dementia

4. have a difficulty in understanding informed consent or refuse to sign the informed consent

5. patients height under 150 cm

Study Design


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Outcome

Type Measure Description Time frame Safety issue
Primary change of the hemodynamic profiles including cardiac index on NICOM during the TURP in elderly patients (Cardiac output, stroke volume, Stroke volume index, Total peripheral resistance, heart rate, blood pressure) change from baseline 1 min before the anesthesia, 10 min after anesthesia, 10 min after surgery, 20 min after surgery, 30 min after surgery, at the end of the surgery
Secondary change of the electrolyte from expected up to 3 months before surgery for preoperative evaluation to expected up to 3 hours after the end of surgery
Secondary change of the hemoglobin from expected up to 3 months before surgery for preoperative evaluation to expected up to 3 hours after the end of surgery
Secondary estimated absorbed irrigation fluid during the surgery Fluid absorbed = % decrease in sodium x ECF (0.2 x body weight) during the surgery
Secondary incidence of TURP syndrome followed for the duration of hospital stay, an expected average of 7 days.
See also
  Status Clinical Trial Phase
Completed NCT01942551 - Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride Phase 1
Completed NCT01436877 - Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia N/A
Completed NCT02822924 - Prostate Artery Embolization for Symptomatic Benign Prostatic Hyperplasia N/A
Completed NCT02390882 - A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH Phase 3
Completed NCT02839122 - A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects Phase 1
Not yet recruiting NCT01861041 - Low Dose Bupivacaine Spinal for Trans Uretral Prostatectomy. Phase 4
Completed NCT02332538 - HoLEP vs. Greenlight 532nm-laser PVEP vs. Bipolar TURP in Management of Moderate/ Large BPH N/A
Completed NCT01835860 - Prostatic Artery Embolization for Benign Prostatic Hyperplasia Phase 2/Phase 3
Completed NCT01665586 - Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study N/A
Completed NCT02038868 - A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia Phase 2
Completed NCT02506465 - Pivotal Study to Assess the Safety and Effectiveness of the iTind Device N/A
Completed NCT01675895 - Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration Phase 4
Recruiting NCT02827578 - Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia Phase 3
Completed NCT02352311 - Safety and Pharmacokinetic Characteristics of DKF-313 Phase 1
Completed NCT01627522 - Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate Phase 2/Phase 3
Completed NCT01494337 - Holmium Laser Enucleation of Prostate(HOLEP) vs Greenlight(XPS) Laser Photoselective Vapo-Enucleation of Prostate(PVEP) Phase 4
Completed NCT01952912 - Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates N/A
Active, not recruiting NCT01736033 - Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients Phase 4
Recruiting NCT02021032 - Post-Marketing Study Using PROLIEVE® for the Treatment of Benign Prostatic Hyperplasia (BPH) Phase 4
Completed NCT00861588 - Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia N/A